Related Experiment Video
Updated: Jun 23, 2026

10:41
A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)
Published on: April 30, 2020
[A social backing program and motivation provision in patients with tuberculosis]
Summary
Tuberculosis patients need social support and financial incentives to complete treatment. Addressing socioeconomic factors like employment and housing is crucial for improving tuberculosis recovery and motivation.
Area of Science:
- Public Health
- Social Medicine
- Tuberculosis Research
Background:
- Tuberculosis (TB) treatment adherence is a global health challenge.
- Patient motivation significantly impacts treatment outcomes.
- Socioeconomic factors often impede successful TB recovery.
Purpose of the Study:
- To investigate tuberculosis patients' needs, perceptions, and expectations regarding healthcare and social support.
- To identify barriers to treatment adherence and inform program improvements.
- To enhance patient motivation for recovery and treatment completion.
Main Methods:
- Anonymous voluntary questionnaires administered to new TB cases in four Russian Federation regions.
- Interviewed 1302 patients undergoing chemotherapy and 87 who had discontinued treatment.
- Utilized a standard questionnaire to gather data on patient experiences and preferences.
Main Results:
- Key reasons for treatment discontinuation included financial necessity (30%), alcohol abuse (30%), and poor health education (25%).
- Patients favored social support in the form of rewards (67%), with preferences for daily (23%) or final bonuses (21%).
- Outpatient treatment was preferred by the majority (67%).
Conclusions:
- Tuberculosis patients encounter significant challenges affecting treatment motivation.
- Additional funding and inter-agency collaboration are essential for effective social support.
- Integrating social organizations and addiction services can optimize social support for TB patients.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
